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OBJECTIVE — To describe patterns of diabetes care and implement benchmarking activities
at the national level.
RESEARCH DESIGN AND METHODS — A total of 86 clinics participated, all using
electronic medical records. Quality indicators were identiﬁed, and software was developed,
enabling the extraction of the information needed for quality-of-care proﬁling.
RESULTS — Overall, 114,249 patients with type 2 diabetes were seen during 2004. A1C was
measuredatleastoncein88.0%ofthepatients,lipidproﬁlein64.6%,bloodpressurein77.2%,
and microalbuminuria in 48.1%. Overall, 43.1% of individuals had A1C 7.0%, 36.6% had
bloodpressure130/85mmHg,and29.8%hadLDLcholesterol100mg/dl.Only5.5%ofthe
patients had achieved all the favorable outcomes. Wide between-center variation was docu-
mented for all indicators.
CONCLUSIONS — This study is the ﬁrst step of a nationwide quality-improvement effort
anddocumentsthepossibilityofobtainingstandardizedinformationtobeusedfordiabetescare
proﬁling and benchmarking activities.
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M
anystudieshaveshownthattreat-
ment goals for diabetes and car-
diovascular risk factors are not
reached in a large proportion of patients
(1–3). Furthermore, a close relationship
between the quality of diabetes care and
risk of cardiovascular events was docu-
mented (4).
SeveralAmericanandEuropeanorga-
nizations have been working for the de-
velopment and ﬁeld-testing of measures
for quality of diabetes care (5–7). These
measures include process and intermedi-
ate outcome indicators, which are used to
monitor quality of care and promote con-
tinuous improvement initiatives (8,9).
In Italy, all citizens are covered by
government health insurance. Primary
care for diabetes is provided by general
practitionersanddiabetesoutpatientclin-
ics.Patientscanchooseoneoftwowaysto
access their health care system or can be
referred to diabetes outpatient clinics by
their general practitioners.
In recent years, a continuous im-
provement effort has been implemented
byanetworkofdiabetesoutpatientclinics
all sharing the samesystem for data extrac-
tion from electronic medical records. This
study describes patterns of diabetes care
and benchmarking activities implemented
at the national level using a prespeciﬁed
setofqualityindicatorsdevelopedbythe
Associazione Medici Diabetologi (AMD).
RESEARCH DESIGN AND
METHODS— Process measures in-
clude percentages of patients monitored
at least once during the previous 12
months for the following parameters:
A1C, blood pressure, lipid proﬁle, mi-
croalbuminuria, and foot examination.
Intermediate outcome measures include
theproportionofpatientswithA1Clevels
7.0% or 8%, blood pressure values
130/85 or 140/90 mmHg, and LDL
cholesterol levels 100 or 130 mg/dl.
A software program was developed to
enable the extraction of the information
needed from electronic medical record
systems used for the everyday manage-
ment of outpatients. Data from all diabetes
outpatient clinics were centrally analyzed
anonymously. All indicators were com-
pared with reference values, or “gold stan-
dard,” established by identifying the best
performers. The gold standard for every in-
dicatorwasrepresentedbythe75thpercen-
tileoftheordereddistributionoftheresults
obtained in the centers.
Results were publicized through a
speciﬁc publication (AMD Annals) and
on a dedicated page of the AMD Web site
(10)anddiscussedwithparticipantsinan
annual meeting. Each individual center
could also measure its performance di-
rectly from the electronic record system,
using speciﬁc queries. The project was
conducted without allocation of extra
resources or ﬁnancial incentives but
through a physician-led effort made
possible by the commitment of the spe-
cialists involved. We report here the re-
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concerning type 2 diabetes.
Toaccountforthehierarchicalnature
of the data and to control for the possible
confounding effects of the different vari-
ables,weusedmultilevelregressionmod-
els to investigate intercenter variability
expressed as the 10th to 90th percentile
range, adjusted for sex, age, and cluster-
ing effect.
RESULTS— Overall, 114,249 pa-
tientswereseenby86diabetesoutpatient
clinics during 2004. Of the patients, 53%
were male, 56% were aged 65 years,
11.1% were on diet alone, and 63.3%
were treated with oral agents and 25.3%
with insulin  oral agents.
Results relative to process indicators,
reported in Table 1, show the gap be-
tween the gold standard and the whole
sample of diabetes outpatient clinics. As
for intercenter variability in the process
measures, a moderate variation for A1C
monitoring was documented, whereas a
wide heterogeneity in between-center
performance was present for blood pres-
sure,lipidproﬁle,microalbuminuria,and
foot monitoring.
Results relative to outcome measures
are reported in Table 1. A small minority
of the patients had achieved all the favor-
able outcomes (5.5%), whereas in 8.8%,
none of the goals were reached. The com-
parison with the gold standard showed a
10–20% lower rate of patients at target in
the whole population compared with in-
dividuals cared for by the best performers.
A wide variation was also docu-
mented for the outcome measures; it was
associated with a parallel intercenter vari-
ation in the use of speciﬁc drug classes.
For example, prescription rates for statins
and ACE inhibitors ranged between
13.2% and 35.5% and between 14.2%
and 29.4%, respectively.
CONCLUSIONS— Our study docu-
ments the feasibility of conducting prac-
tice-based quality-of-care studies across
large numbers of outpatient practices—
after having reached a consensus on
how to measure quality in priority ar-
eas.Thiswasapreliminaryfundamental
step to promote continuous critical
evaluation of current practice, develop
process improvements, and reduce prac-
tice variation.
The “best performers” approach
represented a key feature of the contin-
uousquality-improvementeffortimple-
mented. In fact, clinicians were not
faced with theoretical standards often
perceived as unrealistic in their setting,
but rather with the performance of cen-
ters operating in the same health care
system under similar conditions. By
comparing their own performance with
that of centers reaching better results,
specialists could easily realize the real
marginofimprovementmadepossibleby
increasing the level of attention to disease
monitoring and treatment.
The analysis of process indicators
shows that the level of performance is
consistently higher for some parameters,
such as A1C, blood pressure, and lipid
monitoring,thanforotherssuchasmicro-
albuminuria monitoring or foot examina-
tion. The evaluation of between-center
variabilityfurtherdocumentsheterogene-
ity intherateofperformanceofsomeprocess
measures, such as lipids, microalbuminuria,
and foot monitoring.
As for the outcomes considered, our
study conﬁrms the difﬁculties in reaching
therapeutic goals. The comparison with
the gold standard emphasizes the gap ex-
isting between the results achieved in the
whole sample and those attained by the
best performers. We also documented a
wide variation in the ability to reach the
targets recommended by existing guide-
lines,althoughpartofthisvariationcould
be related to factors not taken into con-
sideration (e.g., diabetes duration and
complications). Nevertheless, such vari-
ability was paralleled by strikingly differ-
entratesofprescriptionsofspeciﬁcdrugs,
thus suggesting a strong need for treat-
ment intensiﬁcation.
In conclusion, our study describes
the ﬁrst step of a nationwide quality-
improvementeffortanddocumentsthatit
is possible to obtain standardized infor-
mation to be used for initiatives of diabe-
tes care proﬁling and benchmarking. The
yearly evaluation of patterns of care, the
disseminationofresults,andtheirdiscus-
sion with the participants is expected to
improvetheperformanceofdiabetesclin-
ics and reduce variability (9).
Table 1—Process and outcome indicators in centers representing the best performers for each indicator and in the overall sample
Best performers
(means  SD or %)
Overall sample
(means  SD or %)
Intercenter variability
(10th to 90th percentile)
Process measures
A1C 1/year 96.8 88.0 66.0–96.9
Blood pressure 1/year 95.5 77.2 17.7–98.0
Lipid proﬁle 1/year 88.4 64.6 15.5–89.9
Microalbuminuria 1 year 76.7 48.1 0.0–89.7
Foot examination 1/year 49.5 22.4 0.1–59.3
Outcome measures
A1C 7.0  1.3 7.4  1.5 6.9–8.2
7.0% 58.1 43.1 20.9–59.5
8.0% 18.2 29.7 17.3–52.1
Systolic blood pressure (mmHg) 134  16 141  19 134–150
Diastolic blood pressure (mmHg) 77  98 1  10 77–85
130/85 mmHg 48.7 36.6 44.0–78.0
140/90 mmHg 45.4 66.2 20.1–50.6
LDL cholesterol (mg/dl) 110  32 118  33 113–125
100 mg/dl 39.5 29.8 23.4–35.1
130 mg/dl 26.4 35.1 28.3–43.2
The last column reports the intercenter variability for the overall sample, adjusted for clustering effect, age, and sex.
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